Neuropeptide Y 13-36 (porcine)
Cat. No. 1177
Alternative Name: NPY 13-36 (porcine)
Biological ActivityNeuropeptide Y2 receptor agonist.
(Modifications: Tyr-24 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Aguirre et al (1990) Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci.Lett. 118 5. PMID: 2259468.
Martire et al (1993) Region-specific inhibition of potassium-evoked [3H]noradrenaline release from rat brain synaptosomes by neuropeptide Y-(13-36). Involvement of NPY receptors of the Y2 type. Eur.J.Pharmacol. 230 231. PMID: 8422905.
Aguirre et al (1995) Increased vasopressor actions of intraventricular neuropeptide Y-(13-36) in spontaneously hypertensive versus normotensive Wistar-Kyoto rats. Possible relationship to increases in Y2 receptor binding in the nucleus tractus solitarius. Brain Res. 684 159. PMID: 7583217.
If you know of a relevant citation for this product please let us know.
Keywords: Neuropeptide Y 13-36 (porcine), supplier, Y2, receptor, agonists, Neuropeptides, Y, Receptors, NPY, NeuropeptideY, (porcine), 13-36, NPY1336
Find multiple products by catalog number
New Products in this Area
Potent neuropeptide S receptor (NPSR) antagonistTC OT 39
Nonpeptide oxytocin and V2 receptor partial agonist; also a V1a receptor antagonistTolvaptan
Potent and selective vasopressin V2 receptor antagonist; renoprotective and orally activeML 00253764 hydrochloride
Melanocortin MC4 receptor antagonist; brain penetrantGSK 1562590 hydrochloride
High affinity, selective urotensin II (UT) receptor antagonistMA 2029
Potent and selective, competitive motilin receptor antagonist; orally activeANQ 11125
Selective motilin receptor antagonist
August 30 - September 4, 2014
Booth Number: 22